NewAmsterdam Pharma Co. NV (NAMS)
36.47
+0.30
(+0.83%)
USD |
NASDAQ |
Dec 12, 12:43
NewAmsterdam Pharma EPS Diluted (Quarterly): -0.6051 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.376 |
| ProQR Therapeutics NV | -0.1221 |
| Merus NV | -1.262 |
| argenx SE | -- |
| Pharming Group NV | 0.109 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -72.00M |
| Revenue (Quarterly) | 0.348M |
| Total Expenses (Quarterly) | 72.35M |
| Enterprise Value | 3.397B |
| Gross Profit Margin (Quarterly) | 81.61% |
| Profit Margin (Quarterly) | -20.69K% |
| Earnings Yield | -5.60% |
| Normalized Earnings Yield | -4.649 |